Pfizer PFE stock has been reeling under the pressure of a declining top line due to a steep drop in revenues from its ...

Pfizer on Monday urged a U.S. appeals court not to revisit its decision to bar an anti-affirmative action group's challenge ...

Shares of Pfizer Inc. PFE advanced 1.26% to $28.05 Friday, on what proved to be an all-around great trading session for the ...

Pfizer's valuation looks attractive, but that doesn't mean the stock is a lock to outperform the broader market.

Pharmaceutical giant Pfizer Inc. (NYSE: PFE) has been trying to enter the weight-loss treatment trend dominated by GLP-1 drug ...

Novartis, Pfizer, Novo Nordisk, and Otsuka Pharmaceutical were scolded by a U.K. industry group for violating a voluntary ...

Will local startups give big pharma its next blockbuster drug? Eli Lilly and Pfizer are launching new biotech incubators in.

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines looks set to continue after London's High Court gave a ...

Pfizer is certainly not a high-growth business, but has a high dividend yield and cheap stock price. Learn why PFE stock is a ...

Pfizer shares have suffered a painful slide as pandemic revenue dried up. But management is committed to maintaining and ...

Our analysis of options history for Pfizer PFE revealed 8 unusual trades. Delving into the details, we found 37% of traders ...

It will be the largest project of its kind in New York history when it’s finished, and preliminary work is already underway ...